0001562180-22-000336.txt : 20220107 0001562180-22-000336.hdr.sgml : 20220107 20220107161647 ACCESSION NUMBER: 0001562180-22-000336 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220106 FILED AS OF DATE: 20220107 DATE AS OF CHANGE: 20220107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linetsky David CENTRAL INDEX KEY: 0001776729 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38977 FILM NUMBER: 22518333 MAIL ADDRESS: STREET 1: C/O PHREESIA, INC. STREET 2: 432 PARK AVENUE S., 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phreesia, Inc. CENTRAL INDEX KEY: 0001412408 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 434 FAYETTEVILLE ST. STREET 2: SUITE 1400 CITY: RALEIGH STATE: NC ZIP: 27601 BUSINESS PHONE: 646-747-9959 MAIL ADDRESS: STREET 1: 434 FAYETTEVILLE ST. STREET 2: SUITE 1400 CITY: RALEIGH STATE: NC ZIP: 27601 FORMER COMPANY: FORMER CONFORMED NAME: Phreesia Inc DATE OF NAME CHANGE: 20070914 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-01-06 false 0001412408 Phreesia, Inc. PHR 0001776729 Linetsky David C/O PHREESIA, INC. 434 FAYETTEVILLE ST., SUITE 1400 RALEIGH NC 27601 false true false false SVP, Life Sciences Common Stock 2022-01-06 4 M false 24314.00 4.71 A 164702.00 D Common Stock 2022-01-06 4 M false 948.00 4.71 A 165650.00 D Common Stock 2022-01-06 4 M false 5688.00 8.03 A 171338.00 D Stock Options (Right to buy) 4.71 2022-01-06 4 M false 24314.00 0.00 D 2028-08-06 Common Stock 24314.00 5689.00 D Stock Options (Right to buy) 4.71 2022-01-06 4 M false 948.00 0.00 D 2028-01-30 Common Stock 948.00 475.00 D Stock Options (Right to buy) 8.03 2022-01-06 4 M false 5688.00 0.00 D 2029-01-16 Common Stock 5688.00 5689.00 D A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of this option vested and became exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. 25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. 25% of this option vested and became exercisable on January 17, 2020, with the remainder vesting in three (3) equal annual installments thereafter. /s/ Allison Hoffman by Power of Attorney for David Linetsky 2022-01-07